New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Oncology December 28,2023
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Oncology December 28,2023
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi
Oncology December 28,2023
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi
Oncology December 28,2023
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Oncology December 28,2023
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Oncology December 28,2023
Adherence to quality indicators low in chronic myeloid leukemia

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl
Oncology December 28,2023
Adherence to quality indicators low in chronic myeloid leukemia

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl
Oncology December 28,2023
Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

by Mary Clare Fischer, Dani K. Dodge-Medlin,University of MichiganDisparities in the number of chronic health conditions that Black women endure compared to other races and ethnicities contribut
Oncology December 28,2023
Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

by Mary Clare Fischer, Dani K. Dodge-Medlin,University of MichiganDisparities in the number of chronic health conditions that Black women endure compared to other races and ethnicities contribut
Oncology December 28,2023
Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m
Oncology December 28,2023
Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m
Oncology December 28,2023
Miami's Little Haiti joins global effort to end cervical cancer

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe
Oncology December 28,2023
Miami's Little Haiti joins global effort to end cervical cancer

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe
Oncology December 28,2023
Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s
Oncology December 28,2023
Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s
Oncology December 28,2023
Examining resistance to immunotherapy in ovarian cancer

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled
Oncology December 28,2023
Examining resistance to immunotherapy in ovarian cancer

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled
Oncology December 28,2023
Ovarian cancer detection takes a step forward

Ovarian cancer detection takes a step forward

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainA new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer
Oncology December 28,2023
Ovarian cancer detection takes a step forward

Ovarian cancer detection takes a step forward

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainA new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer
Oncology December 28,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com